This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
View All Zacks #1 Ranked Stocks
Zacks News
Is Axon (AXON) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Axon (AXON) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AXON's Dedrone Expands in CUAS Capability: Can It Deliver Growth?
by Zacks Equity Research
Axon is expanding its counter-drone footprint as Dedrone boosts CUAS capabilities through AI platforms, acquisitions and new defense partnerships.
WWD Stock Appreciates 85% in 12 Months: What's Triggering the Uptrend?
by Zacks Equity Research
WWD stock is up 85% in a year, driven by aerospace and industrial demand, strong 2026 guidance, major investments and aggressive shareholder returns.
Axon vs. Woodward: Which Aerospace & Defense Stock Should You Bet On?
by Avisekh Bhattacharjee
WWD appears better positioned than AXON, with stronger stock performance, improving estimates and a more attractive valuation in aerospace and defense.
Strength in Software & Services Unit Drives Axon: Can It Sustain?
by Zacks Equity Research
AXON's Software & Services revenues jump 39.6% in the first nine months of 2025 as subscriptions, add-ons and ARR growth fuel a higher outlook guidance.
Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Axon (AXON). This makes it worthwhile to examine what the stock has in store.
Brokers Suggest Investing in Axon (AXON): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Axon (AXON) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Can Axon Sustain Connected Devices Momentum With Solid Market Demand?
by Zacks Equity Research
AXON rides on demand for TASER 10, Axon Body 4 and counter-drone tech as Connected Devices growth accelerates.
Why Is Axon (AXON) Down 15% Since Last Earnings Report?
by Zacks Equity Research
Axon (AXON) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Axon Plunges 31.1% in 6 Months: Should You Hold or Fold the Stock?
by Avisekh Bhattacharjee
AXON's 31% slide contrasts with strong device and software growth as rising costs, debt and valuation cloud near-term sentiment.